JelikaLite is a clinical-stage medical technology company developing wearable neuromodulation devices for developmental pediatric disorders, led by Cognilum, a photobiomodulation system being studied for autism. Its approach combines near-infrared light, sensors and machine-learning personalization in a home-based device intended to support communication and social responsiveness. The company has received FDA Breakthrough Device Designation and Non-Significant Risk Device Study Designation for Cognilum, which remains under development and has not been approved by the FDA for autism.
FDA Breakthrough Device Designation
Compliance program
FDA Non-Significant Risk Device Study Designation
Compliance program